Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Magnetic resonance imaging+1

Not recruiting

Registered drugNo placebo

Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Gadobutrol

Contact Research Centre

Crohn's disease

Not recruiting

InvestigationalNo placebo

Study of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Pf-06480605

Contact Research Centre

Major depression

Not recruiting

InvestigationalNo placebo

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Psilocybine

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha

Contact Research Centre

Chronic lymphocytic leukaemia+1

Not recruiting

InvestigationalNo placebo

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Clear cell renal cell carcinoma

Not recruiting

Registered drug

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Retinopathy of prematurity

Not recruiting

Registered drugNo placebo

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

Registered drugNo placebo

Czechia

Participants:0–17 years
Substances:Aflibercept

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Find therapies in clinical trials near you – page 5

78 trials match your criteria

Psoriatic arthropathy

Study on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent

Chronic myeloid leukaemia

Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

Hidradenitis

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Magnetic resonance imaging+1

Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

Crohn's disease

Study of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients

Major depression

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

Dermatitis atopic

Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

Chronic lymphocytic leukaemia+1

Study Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia

Clear cell renal cell carcinoma

Study of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Retinopathy of prematurity

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

Non-small cell lung cancer

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

Plasma cell myeloma

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.